Skip to content

Clinical trials

Atrial Fibrillation trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Not applicable Clear all

1,646 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20028
20034
20045
200513
200612
200721
200819
200928
201032
201135
201257
201345
201460
201582
201678
201783
201896
201997
2020100
2021109
2022120
2023123
2024129
2025140
2026139

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed706
Unknown status287
Recruiting254
Not yet recruiting136
Terminated103
Active, not recruiting90
Withdrawn49
Enrolling by invitation18
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation40
Abbott Medical Devices38
Yonsei University32
Biosense Webster, Inc.29
Shanghai Chest Hospital25
Beijing Anzhen Hospital20
Medtronic Cardiac Ablation Solutions19
Medtronic Cardiac Rhythm and Heart Failure17
Ottawa Heart Institute Research Corporation17
Barts & The London NHS Trust15

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation1,646
Arrhythmias, Cardiac133
Stroke110
Heart Failure86
Atrial Flutter57
Ischemic Stroke45
Cardiovascular Diseases41
Hypertension33
Heart Diseases30
Tachycardia, Ventricular21

Trials

Showing 76 to 100 of 1,646. Each trial links to its page on Pharma Observatory.

1,546 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.